GlobalData Plc: £9.2m placing of Director’s stock - Singer Capital Markets

Home GlobalData Plc: £9.2m placing of Director’s stock

October 2017 - Uncategorized

GlobalData Plc: £9.2m placing of Director’s stock

In response to demand from institutional investors, Mike Danson, CEO of GlobalData, has sold 1.7 million ordinary shares in the Company via an accelerated bookbuild placing to institutional investors at a price of 540 pence per share (c. £9.2m).

The placing was managed by Singer Capital Markets, acting as sole bookrunner.

Ticker: DATA
Current Market Cap: £ 575m
Website: https://www.globaldata.com/

For more information, email marketing@n1singer.com

Keep Reading …

£169.3m Recommended Sale of Eckoh to Bridgepoint

Arecor Therapeutics plc is a globally focused biopharmaceutical company that is transforming patient care by bringing innovative medicines to market.

Proudly Supporting The Sunday Times 100 Tech

Singer Capital Markets is delighted to be supporting The Times One Hundred League table – ranking Britain’s fastest-growing private companies. The Times One Hundred ranks Britain’s fastest-growing companies who have received a minimum average annual sales growth rate of 62% over the last 3 years.

Singer Capital Markets News

Appointment as Nominated Adviser and Joint Broker to Arecor Therapeutics plc

Arecor Therapeutics plc is a globally focused biopharmaceutical company that is transforming patient care by bringing innovative medicines to market.

Brokership Announcements